INNMF

AMPLIA THERAPEUTICS LTD by Amplia Therapeutics Ltd. (INNMF)

About AMPLIA THERAPEUTICS LTD by Amplia Therapeutics Ltd. (INNMF)

Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. Its immuno-modulator microparticles technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as multiple sclerosis. The company was founded by Christopher J. Burns on May 31, 2000 and is headquartered in Melbourne, Australia.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.16
52 Week Low
$0.03
Market cap
13.6M
Dividend yield
0.00%
Volume
--
Avg. volume
3,789
P/E ratio
-2.41

AMPLIA THERAPEUTICS LTD by Amplia Therapeutics Ltd. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.16
52 Week Low
$0.03
Market cap
13.6M
Dividend yield
0.00%
Volume
--
Avg. volume
3,789
P/E ratio
-2.41